# US 2012/0251615 A1 · Agent for intra-articular injection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251615 A1
- Document ID: US20120251615A1
- Status: Published application
- Kind: A1
- Application number: 13/339,113
- Filed: 2011-12-28
- Published: 2012-10-04
- Earliest claimed: 2011-01-14
- Inventors: Horst KIEF
- Web page: https://patentgrep.com/patent/US20120251615A1

## CPC

- A61K 31/737: Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K31/727 takes precedence)
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 38/1709: {from mammals}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to agents for intra-articular injection that contain a mixture of alpha-tocopherol, phospholipids or poloxamers, proteoglycans, and a cortisone crystal suspension or a cortisone crystal solution. The agents are suitable for therapy of rheumatic diseases, in particular of arthrosis.

## Claims

### Claim 1

Agent for intra-articular injection, wherein it contains a mixture of alpha-tocopherol, phospholipidsor poloxamers, proteoglycans, and a cortisone crystal suspension or a cortisone crystal solution.

### Claim 2 (depends on 1)

Agent according to claim 1, wherein it contains a poloxamer.

### Claim 3 (depends on 1)

Agent according to claim 1, wherein it contains a phospholipid and the phospholipid is phosphatidylcholine.

### Claim 4 (depends on 1)

Agent according to claim 1, wherein it contains chondroitin sulfate as proteoglycan.

### Claim 5 (depends on 2)

Agent according to claim 2, wherein it contains chondroitin sulfate as proteoglycan.

### Claim 6 (depends on 1)

Agent according to claim 1, wherein the mixing ratio of alpha-tocopherol to phospholipids or poloxamers is from 1:1 to 1:2.5.

### Claim 7 (depends on 1)

Agent according to claim 1, wherein the cortisone crystal solution consists of dexamethasone acetate in phospholipids or poloxamers.

### Claim 8 (depends on 1)

Agent according to claim 1, wherein it contains 25 to 75 mg diclofenac in aqueous solution.

### Claim 9 (depends on 2)

Agent according to claim 2, wherein it contains 25 to 75 mg diclofenac in aqueous solution.

### Claim 10 (depends on 1)

Agent according to claim 1, wherein it contains 5 to 15 mg folic acid.

### Claim 11 (depends on 2)

Agent according to claim 2, wherein it contains 5 to 15 mg folic acid.

### Claim 12 (depends on 1)

Agent according to claim 1, wherein it contains liposomes that are formed by adding a medicinal agent-compatible oil to the phospholipid or poloxamer.

### Claim 13 (depends on 12)

Agent according to claim 12, wherein the oil is castor oil.

### Claim 14 (depends on 1)

Agent according to claim 1, wherein a solution of 1% procaine in saline is contained.

### Claim 15 (depends on 2)

Agent according to claim 2, wherein a solution of 1% procaine in saline is contained.

### Claim 16 (depends on 1)

Method of treatment of forms of rheumatic disease, in particular arthrosis, and even more particularly osteoarthritis wherein an agent according to claim 1 is injected into a diseased joint.

### Claim 17 (depends on 2)

Method of treatment of forms of rheumatic disease, in particular arthrosis, and even more particularly osteoarthritis wherein an agent according to claim 2 is injected into a diseased joint.

### Claim 18 (depends on 8)

Method of treatment of forms of rheumatic disease, in particular arthrosis, and even more particularly osteoarthritis wherein an agent according to claim 8 is injected into a diseased joint.

### Claim 19 (depends on 12)

Method of treatment of forms of rheumatic disease, in particular arthrosis, and even more particularly osteoarthritis wherein an agent according to claim 12 is injected into a diseased joint.

### Claim 20 (depends on 15)

Method of treatment of forms of rheumatic disease, in particular arthrosis, and even more particularly osteoarthritis wherein an agent according to claim 15 is injected into a diseased joint.
